IQVIA Holdings Inc. Faces Slump After Earnings Report

IQVIA Holdings Inc. (IQV) has declined 1.1% since its last earnings report. The company's performance is expected to be impacted by factors such as the growth of AI in the software industry. Zacks Investment Research has identified 3 top software stocks poised to skyrocket in the coming months, including IQVIA. Investors can access a free report from Zacks that reveals these top picks.

IQVIA Holdings Inc. (IQV) experienced a 1.1% decline since its last earnings report, as reported on Nasdaq [2]. The company's performance is expected to be influenced by several factors, including the growing significance of AI in the software industry. Zacks Investment Research has identified IQVIA as one of the top software stocks poised to rise in the coming months [2]. Investors can access a free report from Zacks to learn more about these top picks.

IQVIA's recent partnership with Veeva Systems, announced on August 19, 2025, is likely to have an impact on its stock performance [1]. The partnership aims to integrate IQVIA's data and analytics with Veeva's software platforms, such as Veeva Network, Nitro, and EDC, to streamline clinical workflows and AI-driven operations. This collaboration has already resulted in a 0.76% stock increase and a 41.85% surge in trading volume [3].

The partnership resolves pending legal disputes and enables third-party data access agreements, allowing customers to combine IQVIA’s insights with Veeva’s solutions. IQVIA has also joined Veeva’s CRO Clinical Data Partner program, enhancing its ability to accelerate database builds and data delivery for clients. Both companies emphasized the potential for improved efficiency in clinical development and commercial operations, citing combined strengths in AI, technology, and domain expertise [3].

While the partnership is expected to bring benefits, the impact on IQVIA's stock performance remains to be seen. The company's ability to leverage AI and integrate its data with Veeva's platforms will be crucial in determining its future success. Investors should keep an eye on IQVIA's earnings reports and the progress of its partnership with Veeva Systems for further insights.

References:
[1] https://pharmafile.com/news/iqvia-and-veeva-agree-long-term-partnerships-to-support-service-delivery/
[2] https://www.nasdaq.com/articles/iqvia-iqv-down-11-last-earnings-report-can-it-rebound
[3] https://www.ainvest.com/news/iqvia-veeva-strategic-alliance-spikes-trading-volume-41-85-stock-jumps-top-500-list-2508/